Initially, we explored the relationship between YKL-40 and tumor progression hallmarks in CRC using KRAS-mutant HCT116 cells and p53-mutant Caco2 cells subjected to YKL-40 gene silencing and overexpression. This evidence concerns the gene CHI3L1 and colorectal carcinoma.